In a 2021 observational study, microdosers showed statistically significant increases in psychological flexibility over a four-week period (Kaertner et al., Scientific Reports, 2021). That sounds promising, until you hold it up against the double-blind, placebo-controlled trials that followed. There, the flexibility gains disappeared. The picture is genuinely unsettled, and that honesty is where any meaningful conversation about microdosing and mindset needs to start.
What is more settled is this: psychological flexibility itself is one of the most robust predictors of mental wellbeing in clinical psychology. And Acceptance and Commitment Therapy (ACT), the framework built around it, offers practical tools that complement a microdosing practice regardless of whether the substance alone moves the needle on flexibility. This article walks through what the research actually says, where the gaps are, and how you can use ACT-informed practices to bring more structure and self-awareness to your protocol.
What psychological flexibility actually means
Psychological flexibility is the ability to stay open to difficult thoughts and feelings, stay aware of the present moment, and still act in line with what matters most to you. It sounds deceptively simple. In practice, it is one of the hardest things a person can learn to do consistently.
Think of its opposite: rigidity. Getting stuck in the same anxious thought loop. Avoiding situations because of a feeling you do not want to have. Doing things out of habit or fear rather than choice. Most of us recognise these patterns in ourselves. Psychological flexibility is the capacity to notice them, hold them lightly, and choose differently.
ACT organises this capacity into six interconnected processes. None of them are reserved for therapy rooms. They are skills, and like any skill, they can be practised.
The six processes in everyday language
Acceptance. Allowing difficult feelings to be present without fighting them or running from them. Not liking anxiety, but stopping the war against it. You feel the tightness in your chest and let it sit there rather than spiralling into "I need to fix this right now."
Defusion. Creating distance from your thoughts so you can see them as mental events rather than facts. Instead of "I'm a failure," it becomes "I'm having the thought that I'm a failure." Small shift, large consequence.
Present-moment awareness. Paying attention to what is happening right now rather than replaying the past or rehearsing the future. Noticing the texture of your morning coffee rather than scrolling through yesterday's mistakes.
Self-as-context. Recognising that you are the one observing your thoughts and feelings, not the thoughts and feelings themselves. You are the sky, not the weather. This one takes practice to feel, not just understand.
Values. Getting clear on what actually matters to you, beneath the "shoulds" and social expectations. Connection, creativity, honesty, adventure. Your values are not goals to achieve but directions to move in.
Committed action. Taking concrete, values-aligned steps even when it feels uncomfortable. Choosing to have the difficult conversation, start the project, or set the boundary. Action is where flexibility becomes tangible.
Why researchers are studying psychological flexibility and psychedelics
The interest in linking psychedelics to psychological flexibility comes from a reasonable hypothesis. Psychedelic experiences, even at sub-perceptual doses, may loosen rigid patterns of thinking, potentially creating a window of cognitive and emotional openness. If that window exists, it could be a fertile period for building new habits, revising stuck narratives, or engaging more deeply with therapeutic practices like ACT.
The early observational data was encouraging., over four weeks. The study also reported reductions in depression and stress. These findings aligned with broader research on higher-dose psilocybin, where psychological flexibility has been identified as a putative mechanism of change in depression treatment (Agin-Liebes et al., 2024, Journal of Psychopharmacology).
But observational studies have a significant limitation: there is no placebo control, which means expectancy effects, the powerful belief that something will work, cannot be separated from the substance's effects. This matters enormously in microdosing research, where people often have strong expectations about what their practice will do for them. If you are curious about the brain-level picture, our article on the neuroscience of microdosing explores what we know and do not know about mechanism.
What the controlled trials actually found
When researchers moved to more rigorous designs, the flexibility narrative became more complicated. Prochazkova et al. (2026) conducted double-blind, placebo-controlled trials examining cognitive and psychological flexibility in microdosers and found no significant improvements over placebo. Both groups improved, which suggests that the act of participating in a structured protocol, paying attention to your inner life, and expecting change may itself be doing real work. But the psilocybin did not add a measurable extra layer of flexibility in these controlled conditions.
Similarly, a case study examining microdosing for OCD reported reduced symptom severity but no restoration of cognitive flexibility on standardised tasks. The person felt better but did not demonstrate the kind of flexible, set-shifting cognitive performance that researchers expected to see.
The honest summary: observational reports are more positive than blinded data. People who microdose with intention often report feeling more psychologically flexible, but when you control for expectancy, the substance-specific effect on flexibility has not been reliably demonstrated. This does not mean microdosing is inert. It means the mechanism may be more about context, intention, and practice than pharmacology alone.
This is not a reason for disappointment. It is actually an invitation. If the flexibility gains people experience are driven partly by the structure, reflection, and intentionality they bring to their practice, then getting better at those things becomes the priority. And that is exactly where ACT comes in.
Microdosing is not the same as ACT, but they share a direction of travel
ACT is a well-established therapeutic framework with decades of research behind it. Microdosing is an emerging practice with a much thinner evidence base. They are not interchangeable, and neither replaces the other. But they point in a similar direction: towards openness, towards willingness to experience discomfort, towards living by your values rather than your autopilot.
Some people who microdose report a sense of loosening, a subtle shift in how tightly they grip their usual mental narratives. That description maps neatly onto what ACT calls defusion: the ability to step back from a thought and see it as a thought rather than a command. Others describe a heightened awareness on dose days, a quality of attention that resembles present-moment awareness.
The critical point is this: openness without direction does not build lasting change. If microdosing creates a window of receptivity but you spend that window scrolling your phone, the window closes. ACT provides a framework for noticing the openness and channelling it into something meaningful. It gives you specific things to practice, track, and build on. For a deeper look at comparing microdosing protocols and finding one that fits your life, that is worth reading alongside this article.
Microdosing without intentional reflection is unlikely to build lasting psychological flexibility. The substance may contribute, but it is what you do with the experience that compounds over time.
Five ACT-informed practices you can use alongside your protocol
These five practices are drawn from ACT's core processes, adapted for the rhythm of a microdosing protocol. Each one is simple enough to start today. None require a therapist, though working with one can deepen the practice considerably. If you are new to structuring a microdosing practice, our complete guide to microdosing psilocybin covers the fundamentals.
Defusion: naming the story your mind tells on dose days
On dose days, notice what narrative your mind constructs. "This is really working, I can feel it." Or: "Nothing is happening, this is pointless." Both are stories, not facts. Try labelling them: "There's the 'it's working' story" or "My mind is doing the 'nothing ever works for me' thing again." You are not trying to change the thought. You are practising seeing it as a thought. Write the story down in a single sentence. That act of externalising creates distance.
Willingness: sitting with discomfort on off days
Off days can feel flat. Some people feel a pull towards the next dose or towards something else that promises relief. Use this as practice. When discomfort arises, try a willingness check-in: "What am I feeling right now? Can I let this feeling be here for five minutes without doing anything about it?" This is not about suffering stoically. It is about building the muscle of allowing difficult feelings to pass through without needing to fix or flee.
Present-moment awareness: a brief anchor before you dose
Before you take your dose, pause for two minutes. Sit still. Feel your feet on the floor. Take three slow breaths, noticing the sensation of air entering and leaving. Do a brief body scan from your head down to your toes, just noticing what is there. This is not meditation for relaxation. It is an act of arriving. You are anchoring the moment with awareness rather than swallowing a capsule on autopilot.
Values compass: a journaling prompt for any day
Ask yourself one question: "What mattered most to me today, and did my actions move towards it or away from it?" This is not about self-judgement. It is about noticing the gap between what you care about and how you actually spent your time. Over weeks, the pattern reveals whether your practice is supporting the life you want to live or simply becoming another routine.
Afterglow's journaling tools include ACT-informed prompts like the values compass. They are designed to surface patterns across dose and off days, so you can see what is actually shifting over weeks, not just how you feel in the moment.
Committed action: small experiments across your week
Choose one values-aligned behaviour to test this week. It should be specific and slightly uncomfortable. "I will call my friend instead of texting." "I will work on the creative project for 20 minutes before checking email." Track whether you do it on dose days and off days. The goal is not to prove microdosing helps, but to build a habit of acting on your values regardless of how you feel.
How to tell if your flexibility is growing
Psychological flexibility does not announce itself with fireworks. It shows up in small, specific moments. You notice you are in a familiar argument with your partner, and instead of deploying the same defensive script, you pause. You catch yourself mid-story: "There I go again with the 'nobody appreciates me' narrative." You do something that aligns with your values even though it feels awkward or risky.
Here are some concrete signals to watch for:
- You respond differently to a situation that used to trigger a fixed, automatic reaction.
- You notice a thought pattern in real time rather than only recognising it afterwards.
- You tolerate a difficult emotion for longer without reaching for distraction.
- You take a values-driven action even when it is uncomfortable.
- You hold two contradictory feelings at once without needing to resolve them immediately.
These shifts are subtle and easy to miss if you are not tracking them. This is where consistent journaling becomes genuinely valuable, not as a record of how your dose felt, but as a map of how you are changing as a person. Afterglow's pattern recognition is built to surface exactly these kinds of gradual shifts, reflecting back to you what might be hard to see day by day. If you feel like your practice has stalled, our article on what to do when microdosing is not working explores that honestly.
Flexibility is not about feeling good all the time. It is about being able to feel whatever you feel and still move in a direction that matters to you. If your practice is helping you do that more often, something real is happening, regardless of what the pharmacology is or is not contributing.
When rigidity is a signal to seek support
There is an important flipside to everything discussed here. If you have been microdosing with intention, practising these skills, and still notice increasing rigidity, that is worth paying attention to. Rigidity can look like: getting more stuck in rumination, not less. Avoiding more situations rather than fewer. Feeling increasingly dependent on dose days to function. Losing interest in activities or relationships that used to matter.
These patterns do not necessarily mean something is wrong. But they are a signal that what you are currently doing may not be enough, and that professional support could help. A therapist trained in ACT can work with you on these processes in a structured, personalised way that self-guided practice cannot fully replicate. If you are taking any medications, particularly SSRIs or other psychiatric medications, please read our guide on microdosing and SSRIs and consult your healthcare provider before combining them with a microdosing protocol.
Microdosing is not a substitute for therapy. It is not a substitute for medication when medication is needed. And it is not legal in all jurisdictions. The legal status of psilocybin and other substances used in microdosing varies significantly by country and region. Always understand the laws where you live. Our article on who should not microdose covers contraindications in detail.
Building psychological flexibility is a long-term project. It does not depend on any single substance or technique. It depends on your willingness to keep showing up, noticing what is happening, and making choices that align with the life you actually want to live. Whether microdosing plays a role in that process is something only you can evaluate over time, with honesty, and ideally with good tools and good support.
Bring structure to your practice. Afterglow combines ACT-informed education, protocol tracking, and reflective journaling to help you notice what is actually changing. Start building your practice with intention.
References
- Prochazkova, L., et al.. Double-blind, placebo-controlled trials examining cognitive and psychological flexibility in microdosers. [Study details from peer-reviewed publication.]
Disclaimer: This content is for educational and self-reflection purposes only. It is not medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your health practices.